Robitussin – Cough Care Experts

Man coughing

Effective relief from coughs

Robitussin offers a range of sugar free cough syrups specifically developed for different types of cough:

  • Robitussin Dry Cough Medicine
  • Robitussin Mucus Cough Medicine and Congestion Relief 20mg,6mg/ml Oral Solution
  • Robitussin Chesty Cough Medicine

The doses of Robitussin have been carefully determined to achieve the right concentration of the active ingredient in the blood stream for the most effective reduction in cough symptoms. That is why it is so important to recommend patients take the full 10ml dose at the recommended number of times per day.

Order now

Robitussin Dry Cough

Treatment for dry coughs

Robitussin Dry Cough provides relief from persistent dry irritant coughs and contains dextromethorphan (7.5mg per 5ml) – which acts on the cough centre in the brain by blocking the cough reflex to decrease the frequency of cough

  • Suppresses dry coughs
  • Soothing effect
  • Sugar free
Robitussin mucus cough

Treatment for Nasal Congestion with a Mucus Cough

Robitussin Mucus Cough and Congestion Relief contains pseudoephedrine hydrochloride (30mg per 5ml) – which works by shrinking swollen tissues in the nasal passages to allow air to flow freely1

as well as guaifenesin (100mg per 5ml) – an expectorant which facilitates coughing to aid clearance from the throat and lungs.

  • Loosens mucus
  • Clears blocked nose and sinus
  • Non drowsy
  • Sugar free
Robitussin chesty cough

Treatment for Coughs

Robitussin Chesty Cough helps clear mucus and phlegm from the chest and contains guaifenesin (100mg per 5ml) – an expectorant which thins the mucus in the airways, making it less sticky and enabling the patient to cough it up more easily.

  • Loosens mucus
  • Soothing effect
  • Non-drowsy
  • Sugar free

Recommend the Robitussin range for effective relief of coughs

Robitussin range

Robitussin Cough Syrup

A range of sugar free cough syrups specifically developed for different types of cough.

Robitussin Product Information

  • Robitussin Dry Cough Product Information

    Robitussin Dry Cough Medicine. (Dextromethorphan hydrobromide 7.5mg/5ml).

    Indications: For the relief of persistent dry irritant coughs. Dosage: Adults, the elderly and children over 12 years: One 10ml measure up to four times daily. Contraindications: Hypersensitivity to any of the constituents. Use of a monoamine oxidase inhibitor (MAOI), a selective serotonin reuptake inhibitor (SSRI), or other medication for Parkinson's disease, depression, psychiatric, or emotional conditions, or for 14 days after stopping the medication. Use in children under 12 years. Warnings and precautions: Patients suffering from chronic cough as occurs with smoking, asthma or patients suffering from an acute asthma attack, or where cough is accompanied by excessive secretion should be advised to consult a Healthcare Professional before use. Causes of chronic cough should be excluded if symptoms are persistent. Any accompanying symptoms should be actively sought and appropriately investigated/ treated. Stop use and seek medical advice if the cough lasts more than 7 days, comes back or is accompanied by a fever, rash or persistent headache. Cases of dextromethorphan abuse and dependence have been reported. Caution is particularly recommended for adolescents and young adults as well as in patients with a history of drug abuse or psychoactive substances. Caution in patients who are slow metabolizers of CYP2D6 or use CYP2D6 inhibitors as they may experience exaggerated and/or prolonged effects. Patients with rare hereditary problems of fructose intolerance should not take this medicine because it contains sorbitol and maltitol. Contains 23mg sodium and 12mg sodium benzoate per 10 ml dose. Contains amaranth (E123), which may cause allergic reactions. Contains 219.3mg ethanol per 10 ml dose, which should be taken into account in pregnant or breast-feeding women or in high risk groups. Contains 2094mg sorbitol per 10 ml dose, which may cause gastrointestinal discomfort and mild laxative effect. Serotonergic effects have been reported following concomitant administration of SSRIs, MAOIs and CYP2D6 inhibitors. Symptoms may include mental-status changes, autonomic instability, neuromuscular abnormalities and/or gastrointestinal symptoms, and if suspected, treatment should be discontinued. Side effects: Gastrointestinal upset, dizziness, hypersensitivity, drowsiness, mental confusion, Drug dependence or drug withdrawal syndrome.

    Legal category: P. Product licence number: PL 44673/0207. MAH: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. RRP (excl. VAT): 100ml RRP £3.93. 250 ml RRP £7.49 Text prepared: March 2021

  • Robitussin Mucus Cough and Congestion Relief Product Information

    Robitussin Mucus Cough and Congestion Relief 20mg, 6mg/ml Oral Solution. (Guaifenesin 100mg/5ml, Pseudoephedrine hydrochloride 30mg/5ml). Indications: Nasal decongestant and expectorant for the symptomatic relief of respiratory tract disorders. Dosage: Adults, the elderly and children over 12 years: One 10ml measure up to four times daily. Contraindications: Hypersensitivity to any of the ingredients. Use in patients with ischaemic heart disease, thyrotoxicosis, glaucoma, diabetes, enlargement of the prostate or urinary retention. Patients currently receiving or who have within two weeks received, monoamine oxidase inhibitors. Use in children under 12 years of age. Warnings and precautions: Special care is advisable in patients receiving antihypertensive therapy, patients receiving tricyclic antidepressants and patients receiving other sympathomimetic drugs. Causes of chronic cough should be excluded if symptoms are persistent. Accompanying symptoms should be actively sought and treated. Severe skin reaction such as acute generalized exanthematous pustulosis (AGEP) may occur within the first 2 days of treatment, with fever, and numerous, small, mostly non-follicular pustules arising on a widespread oedematous erythema and mainly localized on the skin folds, trunk, and upper extremities. Patients should be monitored and if symptoms such as pyrexia, erythema, or many small pustules are observed, administration of this product should be discontinued, and appropriate measures taken. Some cases of ischaemic colitis have been reported with pseudoephedrine. Discontinue use and seek medical advice if sudden abdominal pain, rectal bleeding or other symptoms of ischaemic colitis develop. Patients are advised to stop use and ask a healthcare professional if the cough lasts more than 7 days, comes back or is accompanied by a fever, rash or persistent headache. Patients with rare hereditary problems of fructose intolerance should not take this medicine because it contains sorbitol and maltitol. Contains 27.5mg sodium, 15.2mg propylene glycol and 12mg sodium benzoate per 10 ml dose. Contains Amaranth (E123), which may cause allergic reactions. Contains 142mg ethanol per 10 ml dose, which should be taken into account in pregnant or breast-feeding women or in high risk groups. Contains 2094mg sorbitol per 10 ml dose, which may cause gastrointestinal discomfort and mild laxative effect. Side effects: Hypersensitivity reactions, agitation, insomnia, hallucinations, dizziness, headache, hyperactivity, cerebral stimulation, palpitation, tachycardia, increased blood pressure, nausea, vomiting, skin rash, urticaria, including acute generalized exanthematous pustulosis (AGEP), urinary retention, ischaemic colitis. Legal category: P. Product licence number: PL 44673/0208. MAH: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. RRP (excl. VAT): 100ml RRP £3.93. Text prepared: January 2021

  • Robitussin Chesty Cough Product Information

    Robitussin Chesty Cough Medicine. (Guaifenesin Ph Eur 100mg/5ml.). Indications: Expectorant for the treatment of coughs. Dosage: Adults, the elderly and children over 12 years: One 10ml measure up to four times daily. Contraindications: Hypersensitivity to any of the constituents. Use in children under 12 years. Warnings and precautions: Causes of chronic cough should be excluded if symptoms are persistent. Accompanying symptoms should be actively sought and treated. Patients are advised to stop use and ask a healthcare professional if the cough lasts more than 7 days, comes back or is accompanied by a fever, rash or persistent headache. Patients with rare hereditary problems of fructose intolerance should not take this product as it contains sorbitol and maltitol. This medicine contains 242 mg ethanol in each 10ml dose (2.3% w/v). To be taken into account in pregnant or breast-feeding women and high-risk groups. Contains 12mg sodium benzoate, 15.2mg propylene glycol and 23.9mg sodium per 10ml dose. Contains 2675mg sorbitol per dose which may cause gastrointestinal discomfort or a mild laxative effect. Side effects: Nausea, vomiting, hypersensitivity reactions. Legal category: GSL. Product licence number: PL 44673/0206 MAH: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K. RRP (excl. VAT): 100ml RRP £3.93. 250ml RRP £7.49. Text prepared: January 2021

Robitussin – Cough Care Experts

Woman sneezing

Cold and flu

Learn more about cold and flu including treatment, when to refer and antibiotics advice.

Find out more

Cold & flu partnership

Focus on cold and flu

Access editorially independent articles and learning materials created by The Royal Pharmaceutical Society supported by a partnership with GSK.

Find out more

Pharmacist & patient

Educational resources

Access educational resources specific to the respiratory health category.

Find out more